APRE icon

Aprea Therapeutics
APRE

Overview Fund Activity

24 hedge funds and large institutions have $10.8M invested in Aprea Therapeutics in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
24
Holders Change
+4
Holders Change %
+20%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SFM
1
Sphera Funds Management
Israel
$1.81M
2
NCM
2
Nantahala Capital Management
Connecticut
$1.38M
3
ACM
3
AIGH Capital Management
Maryland
$3.5M
4
DCM
4
DAFNA Capital Management
California
$918K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$776K

Top Sellers

1
WVP
1
Worth Venture Partners
New Jersey
$0
2
Walleye Capital
2
Walleye Capital
New York
$0
3
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$17K
4
Morgan Stanley
4
Morgan Stanley
New York
$179K
5
SCM
5
Sio Capital Management
New York
$1.85M
Name Market Value Shares Shares
Change 		Shares
Change %
Walleye Capital
26
Walleye Capital
New York
– – -80,000 Closed
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
– – -5 Closed
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
– – – –
1
2